Cathie Wood’s ARK Invest Buys Nearly 60,000 Shares of CRISPR

By Chris Lange Published Dec 30, 10:21AM EST

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Cathie Wood’s ARK Invest Buys Nearly 60,000 Shares of CRISPR — © Bill Oxford / Getty Images

A couple of ARK Invest funds run by ETF star Cathie Wood made a huge buy on Wednesday. Specifically, these exchange-traded funds bought roughly $4.6 million worth of CRISPR Therapeutics AG (NASDAQ: CRSP | CRSP Price Prediction), as the prices of these funds were down about 1% on Wednesday. Note that their performance is fairly negative in the past year.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 14,400 shares of CRISPR, and ARK Innovation ETF (NYSEARCA: ARKK) scooped up 45,500 shares. At Wednesday’s closing price, this would have valued the sales at roughly $4.6 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The innovation ETF is down about 24% and the other is down closer to 36% in the past year.
[nativounit]
Check out all the ARK Invest trades for Wednesday as well:

Fund	Direction	Ticker	Name	Shares
ARKF	Buy	TDOC	TELADOC HEALTH	10,000
ARKG	Buy	TDOC	TELADOC HEALTH	22,500
ARKG	Buy	SGFY	SIGNIFY HEALTH	105,770
ARKG	Buy	PSNL	PERSONALIS	33,753
ARKG	Buy	MASS	908 DEVICES	56,909
ARKG	Buy	CRSP	CRISPR THERAPEUTICS	14,400
ARKG	Buy	BLI	BERKELEY LIGHTS	50,528
ARKG	Buy	BEAM	BEAM THERAPEUTICS	5,855
ARKG	Sell	TXG	10X GENOMICS	33,989
ARKG	Sell	VRTX	VERTEX PHARMACEUTICALS	24,007
ARKK	Buy	VCYT	VERACYTE	38,715
ARKK	Buy	TWOU	2U	107,448
ARKK	Buy	TDOC	TELADOC HEALTH	97,300
ARKK	Buy	SSYS	STRATASYS	249,771
ARKK	Buy	NVTA	INVITAE	51,355
ARKK	Buy	CRSP	CRISPR THERAPEUTICS	45,500
ARKK	Sell	TSLA	TESLA	22,816
ARKQ	Buy	XPEV	XPENG	43,100
ARKQ	Buy	PATH	UIPATH	31,830
ARKQ	Buy	MTLS	MATERIALISE	20,338
ARKQ	Sell	TSLA	TESLA	5,069
ARKW	Buy	TDOC	TELADOC HEALTH	17,000
ARKX	Buy	BLDE	BLADE AIR MOBILITY	28,372

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
[recirclink id=1021518][wallst_email_signup]

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.